vândut de liki24.co.uk
Urgo Start plus Description Hydro-cleansing dressing composed of poly-absorbent gelling polyacrylate fibres with an acrylic core, which guarantee a cleansing and debridement capacity of the wound bed (from slough, fibrin and debris) with a TLC-NOSF healing matrix (lipid-colloidal technology with potassium sucrose octasulfate). UrgoStart Plus Pad is indicated for the treatment of non-infected, exuding wounds, specifically long-standing or potentially long-standing wounds (e.g. vascular wounds, diabetic foot wounds, pressure ulcers), at all stages of the healing process. Upon contact with the wound bed, the extremely hydrophilic polyacrylate cleansing fibers absorb exudate, leading to swelling and subsequent gelation of the fibers, maintaining the moist environment essential for healing and the ability to stimulate gentle autolytic debridement. Meanwhile, the fibers mechanically disintegrate and electrostatically attract slough, fibrin, debris, and bacteria, trapping them in the dressing and limiting bacterial proliferation. They also allow for continuous yet progressive cleansing and debridement of the wound bed and protect the periwound skin thanks to a vertical absorption mechanism. Furthermore, the gelation of the fibers prevents the dressing from adhering to the wound bed, allowing for atraumatic and painless removal for the tissues and the patient, while maintaining a high level of cohesion of the dressing, allowing for removal in one piece. Finally, the composition of the dressing allows for the management of minor bleeding, thanks to its hemostatic properties. The micro-adherent TLC layer, in contact with wound exudate, forms a lipid-colloidal gel, thanks to the interaction between the hydrocolloid particles and petroleum jelly. This creates a moist environment conducive to wound healing and stimulates the proliferation of cells key to tissue repair. The TLC matrix has been shown to stimulate fibroblast proliferation by 70% and increase hyaluronic acid synthesis and collagen production by 53% and 80%, respectively. The lipid substances in the TLC matrix help prevent the dressing from adhering to the wound bed, resulting in dressing changes that are atraumatic for newly formed tissue and painless for the patient. The dressings ease of application and removal, as well as its effectiveness, have also been evaluated in clinical studies on thousands of patients. Furthermore, the presence of sucrose octasulfate in the dressing gives it metalloproteinase modulating properties, allowing for better healing rates than the neutral dressing, with a consequent reduction in healing times, to the point that it has allowed its inclusion in the NICE and IWGDF recommendations as a recommended dressing for the treatment of lower limb and diabetic foot lesions, by virtue of its cost-effectiveness. Upon contact with wound exudate, UrgoStart Plus Pads TLC-NOSF technology gels. Thanks to this hydrophilic gelation and the presence of lipophilic substances in its composition, this technology: - absorbs components of wound exudate, including enzymes called matrix metalloproteinases (MMPs), elevated levels of which have been linked to delayed healing of chronic wounds; - maintains the moist environment necessary for wound healing. Promoting debridement/cleansing: - the fibers trap fibrin, sludge, and debris and cause them to detach from the wound when the dressing is removed. Hemostatic properties: - in case of small hemorrhages, the adsorption of plasma proteins by the polyacrylate fibers leads to the activation of coagulation and the adhesion of platelets, which initiate and have a synergistic effect on blood clotting. Promoting comfort: - The device is soft and flexible, and the gel-like TLC-NOSF technology lubricates the contact surface. These properties make the device conformable, reduce friction, and make it comfortable. To ensure atraumatic removal of the lesion and peri-wound skin and to allow easy removal: - The moist environment prevents exudate from drying out. Furthermore, the gelled TLC-NOSF technology lubricates the contact surface, preventing the dressing from sticking to the wound bed when removed, so it doesnt resist removal and doesnt cause pain to the patient. How to use - The microadherent layer of UrgoStart may adhere to latex surgical gloves. It is therefore recommended to avoid contact or use sterile forceps. - Cleanse the wound with saline solution. - If using an antiseptic, rinse the wound with saline solution before applying UrgoStart Plus Pad and dry the periwound skin. - UrgoStart can be cut with sterile scissors to fit the size of the wound. - The use of UrgoStart Plus does not replace mechanical debridement, if necessary. - Remove the transparent protective films. - Apply the micro-adherent side of UrgoStart Plus to the lesion. - Keep the dressing in place with a secondary dressing, adhesive plaster or bandage, including compression if prescribed. - UrgoStart Plus Pad can be left in place for up to 7 days, depending on clinical conditions and local protocol. Warnings Contraindications: - known sensitivity to the medication or to one of its components; - malignant lesions; - fistula lesions; - lesions from epidermolysis bullosa; - necrotic lesions. - If clinical signs of local infection appear, treatment should be changed to antimicrobial therapy, according to medical advice. - In case of atypical ulcers with signs of induration or excessive granulation, it is recommended to use UrgoStart Plus Pad only after having verified the absence of degeneration associated with the lesion, in order not to delay the diagnosis. - At the beginning of treatment, you may experience a stinging/painful sensation as the healing process begins. This rarely requires discontinuation of therapy. - In the absence of clinical data as a first-line treatment of acute lesions and in the treatment of Epidermolysis Bullosa (even in case of long-standing lesions), the use of UrgoStart Plus Pad is not recommended. - UrgoStart Plus Pad should not be used in a hyperbaric chamber. - In the absence of specific clinical data, UrgoStart is not recommended for the treatment of lesions on children, pregnant or breastfeeding women. - The concomitant use of creams, ointments or emulsions is not recommended. - Do not use if the package is damaged. - Check that the sterile protection is intact before use. Do not use the dressing if it is damaged. - Single use, do not resterilize the dressing. Conservation Store below 25°C and away from sources of light and humidity. Shelf life in intact packaging: 36 months. Format Available in packs of 10 in sizes 6x6 cm and 10x10 cm. Cod. 602892 Cod. 602893
Preț:
Vânzător: Liki24.co.uk
Brand: N/a
